作者
AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, P Munoz, E Johnson, J Meletiadis, Z‐D Pana, M Lackner, P Verweij, Tomáš Freiberger, OA Cornely, SEVTAP Arikan‐Akdagli, E Dannaoui, AH Groll, Katrien Lagrou, A Chakrabarti, F Lanternier, L Pagano, A Skiada, M Akova, MC Arendrup, T Boekhout, A Chowdhary, M Cuenca‐Estrella, J Guinea, J Guarro, S De Hoog, W Hope, S Kathuria, O Lortholary, JF Meis, AJ Ullmann, G Petrikkos, C Lass‐Flörl
发表日期
2014/4
期刊
Clinical Microbiology and Infection
卷号
20
页码范围
27-46
简介
Mycoses summarized in the hyalohyphomycosis group are heterogeneous, defined by the presence of hyaline (non‐dematiaceous) hyphae. The number of organisms implicated in hyalohyphomycosis is increasing and the most clinically important species belong to the genera Fusarium, Scedosporium, Acremonium, Scopulariopsis, Purpureocillium and Paecilomyces. Severely immunocompromised patients are particularly vulnerable to infection, and clinical manifestations range from colonization to chronic localized lesions to acute invasive and/or disseminated diseases. Diagnosis usually requires isolation and identification of the infecting pathogen. A poor prognosis is associated with fusariosis and early therapy of localized disease is important to prevent progression to a more aggressive or disseminated infection. Therapy should include voriconazole and surgical debridement where possible or posaconazole …
引用总数
201420152016201720182019202020212022202320241634404251525357475419